Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-amino-2-methyl-1-propanol-8-bromotheophyllinate
2. Maximum Strength Aqua-ban
1. 606-04-2
2. Pamabrom [usan:usp]
3. Ua8u0kjm72
4. 606-04-2 (salt)
5. 8-bromotheophylline Compound With 2-amino-2-methyl-1-propanol (1:1)
6. 8-bromo-1,3-dimethyl-3,7-dihydro-1h-purine-2,6-dione Compound With 2-amino-2-methylpropan-1-ol (1:1)
7. 2-amino-2-methylpropan-1-ol;8-bromo-1,3-dimethyl-7h-purine-2,6-dione
8. 8-bromo-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione Compound With 2-amino-2-methyl-1-propanol (1:1)
9. Pamabrom [usan]
10. 2-amino-2-methylpropanol 8-bromotheophyllinate
11. Unii-ua8u0kjm72
12. Backaid
13. Pamabrom (usp)
14. Einecs 210-103-4
15. Pamabrom [mi]
16. Pamabrom [vandf]
17. Pamabrom [mart.]
18. Pamabrom [who-dd]
19. Schembl92712
20. Chembl2104825
21. Pamabrom [usp Monograph]
22. Dtxsid80209397
23. Mfcd00867328
24. S5555
25. Akos016339632
26. Ccg-213575
27. Cs-1106
28. Db11106
29. Ks-5228
30. As-11777
31. Hy-17391
32. Db-053667
33. Ft-0603488
34. P2359
35. D08962
36. T72689
37. 8-bromotheophylline 2-amino-2-methyl-1-propanol
38. 606p042
39. A832802
40. Q7129023
41. 8-bromo-1,3-dimethyl-3,9-dihydro-purine-2,6-dione
42. 2-amino-2-methylpropanol-1-8-bromotheophyllinate
43. 8-bromo-1,3-dimethyl-1h-purine-2,6(3h,7h)-dione Compound With 2-amino-2-methylpropan-1-ol (1:1)
Molecular Weight | 348.20 g/mol |
---|---|
Molecular Formula | C11H18BrN5O3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 347.05930 g/mol |
Monoisotopic Mass | 347.05930 g/mol |
Topological Polar Surface Area | 116 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 340 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
45
PharmaCompass offers a list of Pamabrom API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pamabrom manufacturer or Pamabrom supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pamabrom manufacturer or Pamabrom supplier.
PharmaCompass also assists you with knowing the Pamabrom API Price utilized in the formulation of products. Pamabrom API Price is not always fixed or binding as the Pamabrom Price is obtained through a variety of data sources. The Pamabrom Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pamabrom manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pamabrom, including repackagers and relabelers. The FDA regulates Pamabrom manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pamabrom API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pamabrom manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pamabrom supplier is an individual or a company that provides Pamabrom active pharmaceutical ingredient (API) or Pamabrom finished formulations upon request. The Pamabrom suppliers may include Pamabrom API manufacturers, exporters, distributors and traders.
click here to find a list of Pamabrom suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pamabrom written confirmation (Pamabrom WC) is an official document issued by a regulatory agency to a Pamabrom manufacturer, verifying that the manufacturing facility of a Pamabrom active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pamabrom APIs or Pamabrom finished pharmaceutical products to another nation, regulatory agencies frequently require a Pamabrom WC (written confirmation) as part of the regulatory process.
click here to find a list of Pamabrom suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pamabrom as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pamabrom API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pamabrom as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pamabrom and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pamabrom NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pamabrom suppliers with NDC on PharmaCompass.
Pamabrom Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pamabrom GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pamabrom GMP manufacturer or Pamabrom GMP API supplier for your needs.
A Pamabrom CoA (Certificate of Analysis) is a formal document that attests to Pamabrom's compliance with Pamabrom specifications and serves as a tool for batch-level quality control.
Pamabrom CoA mostly includes findings from lab analyses of a specific batch. For each Pamabrom CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pamabrom may be tested according to a variety of international standards, such as European Pharmacopoeia (Pamabrom EP), Pamabrom JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pamabrom USP).